4723-9-02 Requirements for a course of study in advanced pharmacology.

(A) To be acceptable to the board, a course of study shall meet the following requirements:

(1) Be a minimum of forty-five contact hours in length and include content which ensures sufficient preparation for the safe and effective prescribing of drugs and therapeutic devices;

(2) Include content which is specific to the participant’s nursing specialty and which includes all of the following:

(a) A minimum of thirty-six hours of training, obtained from a single provider, in:

(i) Pharmacokinetic principles and clinical application; and

(ii) Principles of the use of drugs and therapeutic devices in the prevention of illness and maintenance of health;

(b) A combined six hours of training consistent with divisions (B)(3)(b) and (B)(3)(c) of section 4723.482 of the Revised Code.

(3) Include a process for interaction of the participants with instructional personnel;

(4) Include a process for evaluating the participants’ learning of the content required by this rule that includes:

(a) Successful completion of case studies or written assignments;

(b) Successful completion of a comprehensive written examination; and

(c) A mechanism to assure the security of the evaluation process;

(5) Be faculty-directed and obtained either from:

(a) An accredited educational institution acceptable to the board; or

(b) A continuing education program in pharmacology that has been approved by a board approver according toChapter 4723-14 of the Administrative Code.

Effective: 02/01/2011

R.C. 119.032 review dates: 10/08/2010 and 10/01/2015

Promulgated Under: 119.03

Statutory Authority: 4723.50

Rule Amplifies: 4723.482

Prior Effective Dates: 10/01/2001, 02/01/2002, 02/01/2003, 04/01/2006